PharmacovigilanceOfficial

PRAC publishes final EU-language translations of phenobarbital product information in targeted signal procedure

🇪🇺 EMA · PRAC · Fri 13 Nov 2026

The EMA's PRAC has released the final translations of product information text for phenobarbital, linked to a targeted signal management procedure.

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has published the final translations into EU languages of the product information text arising from a targeted signal management (TSM) procedure on phenobarbital. The item is dated 13 November 2026.

The material available to VigiEye consists only of the title and a short summary. It does not set out the nature of the safety signal, the specific changes to the product information, or any timelines for implementation. Those details are therefore not reported here.

As general context, a targeted signal management procedure is a streamlined route within EU pharmacovigilance for assessing a specific safety signal. Where the outcome leads to changes in the product information, translations in the official EU languages are published so that national authorities and marketing authorisation holders can implement the wording.

What it means for your team

  • Marketing authorisation holders for phenobarbital-containing products should check the full EMA publication for the exact wording and any required variations.
  • Regulatory and labelling teams should compare the final EU-language texts with their current national product information.
  • Pharmacovigilance teams should note the procedure outcome for ongoing signal monitoring of phenobarbital, once the substance of the signal is confirmed from the primary document.

Official source: EMA · PRAC ↗

Article written by VigiEye from the official source (EMA · PRAC). AI-assisted; check the source before acting.

More Pharmacovigilance All →